database
While Eudamed is at the center of Europe's new IVD Regulation, its rollout has taken longer than expected, and only some of its modules are currently operational and have been tested.
Sophia Genetics, Memorial Sloan Kettering, AstraZeneca Partner to Broaden Cancer Sequencing Access
The companies aim to create a decentralized global network for genomic cancer testing, including underserved regions where access remains limited.
Day Zero Diagnostics Aiming to Bring Whole-Genome Sequencing Pathogen ID/AST to Clinical Labs
Premium
The firm intends to use new funding to move its platform into the clinical trial stage in the pursuit of an FDA-regulated IVD product.
MetaSight Diagnostics, Maccabi's KSM Partner for Large-Scale Metabolomics Research Study in Israel
The startup is working with the Israeli HMO Maccabi Health Services to develop liquid biopsy assays for cancer and other illnesses.
Genomill, Finland's iCAN Partner to Improve Geno1 Cancer Detection With Biobank Samples
The molecular diagnostic firm will use iCAN's database of genomic and clinical data to help improve the sensitivity of its liquid biopsy technology.
Jul 29, 2020
Sema4 Raises $121M in Series C Financing Round
Jan 18, 2019
Jul 30, 2018